This is the authors' abstract. We don't add key points for this paper.
Increasing access to sterile syringes through pharmacies requires the repeal or modification of legal barriers. Pharmacy sale of syringes to IDUs is an inexpensive HIV prevention intervention with the potential to substantially reduce HIV transmission. Further studies are needed to document how changes to legal barriers can influence HIV prevention for IDUs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Taussig et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: